Zeeba Zahra Sultana1, Farhana Ul Hoque2, Joseph Beyene3, Md Akhlak-Ul-Islam4, Md Hasinur Rahman Khan5, Shakil Ahmed6, Delwer Hossain Hawlader7, Ahmed Hossain8,9,10. 1. CAPABLE- A Cambridge-led program in Bangladesh, University of Cambridge, Cambridge, UK. 2. Department of Public Health, North South University, Dhaka, Bangladesh. 3. Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. 4. Department of Hematology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. 5. Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh. 6. Global Health Institute, North South University, Dhaka, Bangladesh. 7. Health Management BD Foundation, Dhaka, Bangladesh. 8. Department of Public Health, North South University, Dhaka, Bangladesh. ahmed.hossain@utoronto.ca. 9. Global Health Institute, North South University, Dhaka, Bangladesh. ahmed.hossain@utoronto.ca. 10. Health Management BD Foundation, Dhaka, Bangladesh. ahmed.hossain@utoronto.ca.
Abstract
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a serious threat to global efforts to combat tuberculosis. Inconsistent findings on the association between HIV infection and MDR-TB were present in many studies. We aimed to review existing data on the relationship between HIV infection and MDR-TB systematically to assess the contribution of HIV on MDR-TB worldwide. We also investigated the patterns of MDR-TB by age, country-wise income, study designs, and global regions. METHODS: We utilized PubMed, Google Scholar, and ScienceDirect databases to select eligible studies for meta-analysis that were published between January 12,010, and July 30, 2020. The random-effects model was used to obtain the pooled odds ratio of the crude association between HIV and MDR-TB with a 95% confidence interval. We investigated the potential publication-bias by checking funnel plot asymmetry and using the Egger's test. Moreover, we assessed the heterogeneity using the I2 statistic. Sensitivity analysis was performed based on sample size and adjustment factors. The protocol was registered with PROSPERO-CRD42019132752. RESULTS: We identified 1603 studies through a database search, and after subsequent eliminations we selected 54 studies including 430,534 TB patients. The pooled odds of MDR-TB was 1.42 times higher in HIV-positive patients than HIV-negative patients (OR=1.42,CI=1.17-1.71, I2=75.8%). Subgroup analysis revealed that the estimated pooled odds for South-East Asian countries was 1.86, which is the highest in WHO regions (OR=1.86,CI=1.30-2.67, I2=0.00%), followed by Europe and Africa. The effect estimate was found to be higher for primary MDR-TB (OR=2.76,CI=1.70-4.46, I2=0.00%). There was also a trend towards increased odds of MDR-TB for HIV patients older than 40 years (OR=1.56,CI=1.17-2.06). The association was found to be significant in high-burden TB countries (OR=1.75, CI=1.39-2.19) and in high-income countries (OR=1.55, CI=1.06-2.27). CONCLUSION: Such findings indicate that HIV infection raises the risk of MDR-TB, and after contrasting it with the results of the earlier pooled study, it appeared to be an upward risk trend. Moreover, we found that the risk is the highest in the South-East Asian region. A balanced allocation of resources is needed to halt both primary and secondary MDR-TB, particularly in HIV infected people with 40 years of age and older.
BACKGROUND:Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a serious threat to global efforts to combat tuberculosis. Inconsistent findings on the association between HIV infection and MDR-TB were present in many studies. We aimed to review existing data on the relationship between HIV infection and MDR-TB systematically to assess the contribution of HIV on MDR-TB worldwide. We also investigated the patterns of MDR-TB by age, country-wise income, study designs, and global regions. METHODS: We utilized PubMed, Google Scholar, and ScienceDirect databases to select eligible studies for meta-analysis that were published between January 12,010, and July 30, 2020. The random-effects model was used to obtain the pooled odds ratio of the crude association between HIV and MDR-TB with a 95% confidence interval. We investigated the potential publication-bias by checking funnel plot asymmetry and using the Egger's test. Moreover, we assessed the heterogeneity using the I2 statistic. Sensitivity analysis was performed based on sample size and adjustment factors. The protocol was registered with PROSPERO-CRD42019132752. RESULTS: We identified 1603 studies through a database search, and after subsequent eliminations we selected 54 studies including 430,534 TBpatients. The pooled odds of MDR-TB was 1.42 times higher in HIV-positive patients than HIV-negative patients (OR=1.42,CI=1.17-1.71, I2=75.8%). Subgroup analysis revealed that the estimated pooled odds for South-East Asian countries was 1.86, which is the highest in WHO regions (OR=1.86,CI=1.30-2.67, I2=0.00%), followed by Europe and Africa. The effect estimate was found to be higher for primary MDR-TB (OR=2.76,CI=1.70-4.46, I2=0.00%). There was also a trend towards increased odds of MDR-TB for HIV patients older than 40 years (OR=1.56,CI=1.17-2.06). The association was found to be significant in high-burden TB countries (OR=1.75, CI=1.39-2.19) and in high-income countries (OR=1.55, CI=1.06-2.27). CONCLUSION: Such findings indicate that HIV infection raises the risk of MDR-TB, and after contrasting it with the results of the earlier pooled study, it appeared to be an upward risk trend. Moreover, we found that the risk is the highest in the South-East Asian region. A balanced allocation of resources is needed to halt both primary and secondary MDR-TB, particularly in HIV infectedpeople with 40 years of age and older.
Authors: Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym Journal: Lancet Infect Dis Date: 2018-12-13 Impact factor: 25.071
Authors: L Aaron; D Saadoun; I Calatroni; O Launay; N Mémain; V Vincent; G Marchal; B Dupont; O Bouchaud; D Valeyre; O Lortholary Journal: Clin Microbiol Infect Date: 2004-05 Impact factor: 8.067
Authors: Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye Journal: Arch Intern Med Date: 2003-05-12
Authors: Mahfuza Rifat; John Hall; Christopher Oldmeadow; Ashaque Husain; Sven Gudmund Hinderaker; Abul Hasnat Milton Journal: BMJ Open Date: 2015-09-08 Impact factor: 2.692
Authors: Olga P Frolova; Olga V Butylchenko; Patimat G Gadzhieva; Margarita Yu Timofeeva; Valeria A Basangova; Vladislava O Petrova; Inna A Fadeeva; Maria I Kashutina; Nadezhda N Zabroda; Artem A Basov; Elena V Belova; Yury V Zhernov; Oleg V Mitrokhin; Inga I Enilenis; Lyudmila P Severova Journal: Trop Med Infect Dis Date: 2022-05-31
Authors: Heather I Henderson; Sonia Napravnik; Michael R Kosorok; Emily W Gower; Alan C Kinlaw; Allison E Aiello; Billy Williams; David A Wohl; David van Duin Journal: Open Forum Infect Dis Date: 2022-09-17 Impact factor: 4.423